Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The effect of calcium treatment on creatinine was only partially mediated by a concomitant increase in blood total calcium concentration and was independent of randomized vitamin D treatment.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Randomised controlled trial.

Randomised controlled trial

Assigns participants or groups to comparison interventions by chance.

Meta-analysis unclear · Double-blind reported · Human research reported

Reported blinded roles: investigators.

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Calcium Supplementation Increases Blood Creatinine Concentration in a Randomized Controlled Trial

Source: Article title.

The following institutional review boards (IRBs) approved the study prior to its initiation at that site (date of initial approvals are in parentheses): Dartmouth College Committee for the Protection of Human Subjects (8/25/03), University of Southern California IRB (3/17/04), Kaiser Permanente IRB (5/27/04), Colorado Multiple Institutional Review Board (7/23/04), Emory University IRB (4/12/04), Atlanta Veterans Affairs Medical Center (VAMC) IRB (4/12/04), University of Iowa IRB (6/9/04), University of Minnesota IRB (6/3/04), Minneapolis VAMC IRB (6/29/04), Portsmouth Regional Hospital IRB (3/24/04), Concord Hospital IRB (4/1/04), Maine Medical Center IRB (6/7/04), White River Junction VAMC IRB (3/4/04), University of North Carolina IRB (5/24/04), Cleveland Clinic IRB (5/21/04), University of Puerto Rico IRB (9/25/06), San Juan VAMC IRB (11/7/06), Palmetto Health IRB (4/13/04), University of Texas/MD Anderson Cancer Center IRB (4/7/04).

Source: Methods.

The Vitamin D/Calcium Polyp Prevention Study was a multicenter, placebo-controlled, double-blind, randomized clinical trial investigating the efficacy of vitamin D, calcium, or both for preventing sporadic colorectal adenoma recurrence.

Source: Methods.

Participants, health care providers and investigators were blinded to treatment assignments.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Calcium Supplementation Increases Blood Creatinine Concentration in a Randomized Controlled Trial

Randomised controlled trial · PLoS ONE · 2014

Original publication title

Calcium Supplementation Increases Blood Creatinine Concentration in a Randomized Controlled Trial

Elizabeth L. Barry; Leila A. Mott; Michal L. Melamed; Judith R. Rees; Anastasia Ivanova; Robert S. Sandler; Dennis J. Ahnen; Robert S. Bresalier; Robert W. Summers; Roberd M. Bostick; John A. Baron

© 2014 Barry et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Among healthy adults participating in a randomized clinical trial, daily supplementation with 1200 mg of elemental calcium caused a small increase in blood creatinine. If confirmed, this finding may have implications for clinical and public health recommendations for calcium supplementation.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Calcium supplements are widely used among older adults for osteoporosis prevention and treatment. However, their effect on creatinine levels and kidney function has not been well studied.

Source: Background

Abstract: What methods does the paper describe?

We investigated the effect of calcium supplementation on blood creatinine concentration in a randomized controlled trial of colorectal adenoma chemoprevention conducted between 2004 to 2013 at 11 clinical centers in the United States. Healthy participants (N = 1,675) aged 45 to 75 with a history of colorectal adenoma were assigned to daily supplementation with calcium (1200 mg, as carbonate), vitamin D3 (1000 IU), both, or placebo for three or five years. Changes in blood creatinine and total calcium concentration were measured after one year of treatment and multiple linear regression was used to estimate effects on creatinine concentrations.

Source: Methods

Abstract: Results

After one year of treatment, blood creatinine was 0.013±0.006 mg/dL higher on average among participants randomized to calcium compared to placebo after adjustment for other determinants of creatinine (P = 0.03). However, the effect of calcium treatment appeared to be larger among participants who consumed the most alcohol (2 to 6 drinks/day) or whose estimated glomerular filtration rate (eGFR) was less than 60 ml/min/1.73 m2 at baseline. The effect of calcium treatment on creatinine was only partially mediated by a concomitant increase in blood total calcium concentration and was independent of randomized vitamin D treatment.

There did not appear to be further increases in creatinine after the first year of calcium treatment.

Source: Results

Abstract: Conclusions

Among healthy adults participating in a randomized clinical trial, daily supplementation with 1200 mg of elemental calcium caused a small increase in blood creatinine. If confirmed, this finding may have implications for clinical and public health recommendations for calcium supplementation.

Source: Conclusions
Authors’ abstract

Background

Calcium supplements are widely used among older adults for osteoporosis prevention and treatment. However, their effect on creatinine levels and kidney function has not been well studied.

Methods

We investigated the effect of calcium supplementation on blood creatinine concentration in a randomized controlled trial of colorectal adenoma chemoprevention conducted between 2004 to 2013 at 11 clinical centers in the United States. Healthy participants (N = 1,675) aged 45 to 75 with a history of colorectal adenoma were assigned to daily supplementation with calcium (1200 mg, as carbonate), vitamin D3 (1000 IU), both, or placebo for three or five years. Changes in blood creatinine and total calcium concentration were measured after one year of treatment and multiple linear regression was used to estimate effects on creatinine concentrations.

Results

After one year of treatment, blood creatinine was 0.013±0.006 mg/dL higher on average among participants randomized to calcium compared to placebo after adjustment for other determinants of creatinine (P = 0.03). However, the effect of calcium treatment appeared to be larger among participants who consumed the most alcohol (2 to 6 drinks/day) or whose estimated glomerular filtration rate (eGFR) was less than 60 ml/min/1.73 m2 at baseline. The effect of calcium treatment on creatinine was only partially mediated by a concomitant increase in blood total calcium concentration and was independent of randomized vitamin D treatment.

There did not appear to be further increases in creatinine after the first year of calcium treatment.

Conclusions

Among healthy adults participating in a randomized clinical trial, daily supplementation with 1200 mg of elemental calcium caused a small increase in blood creatinine. If confirmed, this finding may have implications for clinical and public health recommendations for calcium supplementation.

Trial Registration

ClinicalTrials.gov NCT00153816

Publication and source details

Original title: Calcium Supplementation Increases Blood Creatinine Concentration in a Randomized Controlled Trial

Elizabeth L. Barry; Leila A. Mott; Michal L. Melamed; Judith R. Rees; Anastasia Ivanova; Robert S. Sandler; Dennis J. Ahnen; Robert S. Bresalier; Robert W. Summers; Roberd M. Bostick; John A. Baron

PLoS ONE · 2014

* E-mail: Elizabeth.L.Barry@dartmouth.edu

Competing Interests: Pfizer Consumer Healthcare provided the study pills. JAB and the Trustees of Dartmouth College hold a use patent for calcium chemoprevention, which is not currently licensed. The United States patent is #6251439 and the title is “Composition and method for reducing the risk of carcinogenesis”. The authors would like to confirm that co-author JRR is a current PLOS ONE editorial board member. This does not alter the authors' adherence to PLOS ONE editorial policies and criteria.

Conceived and designed the experiments: JAB RMB RWS RSB DJA RSS ELB. Performed the experiments: RSS DJA RSB RWS RMB. Analyzed the data: LAM AI ELB. Wrote the paper: ELB LAM MLM JRR AI RSS DJA RSB RWS RMB JAB.

© 2014 Barry et al2014Barry et alhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.This study was supported by grants from the National Institutes of Health, National Cancer Institute (#CA098286 to JAB) and National Institute of Diabetes, Digestive and Kidney Diseases (#DK078774 to MLM). Pfizer Consumer Healthcare provided the study pills. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T11:22:19.093057+00:00

DOI: 10.1371/journal.pone.0108094 · PMC4198086